Financials Guanze Medical Information Industry (Holding) Co., Ltd.
Equities
2427
KYG4315D1060
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 HKD | -.--% | -.--% | +40.85% |
05-02 | Guanze Medical Information's Profit Up in 2023 | MT |
03-28 | Guanze Medical Information Industry Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Capitalization 1 | 1,300 | 613.1 |
Enterprise Value (EV) 1 | 1,298 | 566.5 |
P/E ratio | 58.4 x | 22.2 x |
Yield | 1.36% | 2.95% |
Capitalization / Revenue | 7.34 x | 3.93 x |
EV / Revenue | 7.33 x | 3.63 x |
EV / EBITDA | 25 x | 12.8 x |
EV / FCF | -19,385,152 x | 9,055,420 x |
FCF Yield | -0% | 0% |
Price to Book | 5 x | 2.28 x |
Nbr of stocks (in thousands) | 950,000 | 950,000 |
Reference price 2 | 1.369 | 0.6453 |
Announcement Date | 27/04/23 | 29/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 140.8 | 184.4 | 211.1 | 177.1 | 156.1 |
EBITDA 1 | 30.62 | 41.26 | 35.62 | 51.85 | 44.34 |
EBIT 1 | 29.5 | 39.05 | 32.35 | 47.68 | 38.7 |
Operating Margin | 20.95% | 21.17% | 15.33% | 26.92% | 24.8% |
Earnings before Tax (EBT) 1 | 29.6 | 39 | 33.06 | 29.96 | 38.65 |
Net income 1 | 22.32 | 29.04 | 22.94 | 17.94 | 27.57 |
Net margin | 15.85% | 15.75% | 10.87% | 10.13% | 17.66% |
EPS | - | - | - | 0.0234 | 0.0290 |
Free Cash Flow | - | 10.56 | -9.354 | -66.96 | 62.56 |
FCF margin | - | 5.72% | -4.43% | -37.81% | 40.08% |
FCF Conversion (EBITDA) | - | 25.59% | - | - | 141.07% |
FCF Conversion (Net income) | - | 36.35% | - | - | 226.92% |
Dividend per Share | - | - | - | 0.0186 | 0.0191 |
Announcement Date | 14/12/22 | 14/12/22 | 14/12/22 | 27/04/23 | 29/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt 1 | 40.2 | 33.2 | - | - | - |
Net Cash position 1 | - | - | 0.45 | 2.37 | 46.6 |
Leverage (Debt/EBITDA) | 1.312 x | 0.8058 x | - | - | - |
Free Cash Flow | - | 10.6 | -9.35 | -67 | 62.6 |
ROE (net income / shareholders' equity) | - | 33.6% | 17.7% | 8.64% | 10.5% |
ROA (Net income/ Total Assets) | - | 16.8% | 11.3% | 11.2% | 7.56% |
Assets 1 | - | 172.4 | 203 | 160.1 | 364.8 |
Book Value Per Share | - | - | - | 0.2700 | 0.2800 |
Cash Flow per Share | - | - | - | 0.0300 | 0.0700 |
Capex 1 | 7.49 | 11.5 | 7.81 | 9.33 | 7.3 |
Capex / Sales | 5.32% | 6.26% | 3.7% | 5.27% | 4.68% |
Announcement Date | 14/12/22 | 14/12/22 | 14/12/22 | 27/04/23 | 29/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+40.85% | 121M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- 2427 Stock
- Financials Guanze Medical Information Industry (Holding) Co., Ltd.